Clinical trial for Prevention
Official title Kimel Family Centre for Brain Health and Wellness
ClinicalTrials.gov ID: NCT06933667
What this study is testing
- What it's testing
- The study wants to see if a personalized risk assessment and tailored program can lower dementia risk and improve cognition.
- Who it's for
- Adults 50 years or older who do not yet have dementia and can speak English.
- What's involved
- Participants get a detailed risk report, then join programs at the centre to work on exercise, diet, brain activities, social contact, and mental health. Their risk and cognition are checked every six months and a full review is done yearly.
- Time commitment
- The program lasts at least one year, with risk and cognition checks every six months and a comprehensive assessment each year.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 50 and older. Healthy volunteers may be eligible.
You may be able to join if
- Aged 50 years or older
- Sufficiently fluent in English to complete the assessments and participate in programming.
You likely can't join if
- Diagnosis of dementia.
The study team makes the final eligibility decision.
Where it is enrolling
- Toronto, Ontario, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 50 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Toronto, Ontario, Canada. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.